Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

SDGR Price Correlated With Financials For Schrodinger

Free historical financial statements for Schrodinger Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 9 quarters since 2020. Compare with SDGR stock chart to see long term trends.

SDGR Stock Compared to Quarterly

SDGR Income Statement

Revenue, Net:48663000
Revenue Per Share:0.6849
Cost of Goods & Services Sold:20680000
Gross Profit:27983000
Selling, General & Admin Expense:22133000
Research & Development Expense:27822000
Total Operating Expenses:56626000
Operating Income:-34479000
Income Taxes:37000
Net Income:-34451000
Earnings Per Share, Basic:-0.48
Shares Outstanding, Basic Avg:71050432

SDGR Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:969000
Change in Accounts Receiveable:-2935000
Net Cash from Operations:-39722000
Net Cash from Operations Per Share:-0.5591
Net Cash from Financing Activities:908000
Property, Plant & Equipment Purchases:1696000
Purchases of Businesses, Net of Cash:6427000
Net Cash from Investing Activities:36304000
Net Change in Cash & Equivalents:-2510000

SDGR Balance Sheet

Cash and Cash Equivalents:120757000
Short-Term Investments:408275000
Accounts Receivable, Net:29321000
Total Current Assets:586168000
Property, Plant & Equipment, Net:11120000
Total Assets:719537000
Accounts Payable:9766000
Total Short-Term Liabilities:85532000
Total Liabilities:188867000

Data imported from Schrodinger Inc SEC filings. Check original filings before making any investment decision.